Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MTG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HSPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGLV6-57 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
QTRT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFAND5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSNK1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V0A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NREP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930373 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHX35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUNDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPALPP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRRM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR5P3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIER2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on